Table I.
Twelve cases applied to NanoString nCounter® PanCancer Immune Profiling.
| Case no. | Prognosis group | Histological diagnosis | Site | AJCC stage | FU data |
|---|---|---|---|---|---|
| 1 | Good | UPS | Upper extremity | II | Survival |
| 2 | Good | UPS | Lower extremity | II | Survival |
| 3 | Good | UPS | Lower extremity | III | Survival |
| 4 | Good | UPS | Lower extremity | II | Survival |
| 5 | Good | UPS | Lower extremity | III | Survival |
| 6 | Good | UPS | Lower extremity | II | Survival |
| 7 | Good | UPS | Lower extremity | III | Survival |
| 8 | Poor | HG myxofibrosarcoma | Upper extremity | II | Death |
| 9 | Poor | UPS | Lower extremity | III | Death |
| 10 | Poor | UPS | Lower extremity | III | Death |
| 11 | Poor | HG myxofibrosarcoma | Lower extremity | II | Death |
| 12 | Poor | UPS | Upper extremity | III | Death |
UPS, undifferentiated pleomorphic sarcoma; HG, high grade; AJCC, American Joint Committee on Cancer; FU, follow up.